Univariate analysis identified disease stage and STMN1 and TS levels as significant prognostic markers for OS in patients with an adenocarcinoma component, and disease stage and VEGFR2 and TUBB3 levels as significant prognostic markers for OS in patients with a non-adenocarcinoma component. The gene discussed is TYMS; the disease is adenocarcinoma.